In a first column on the page 15092, in the section “Compound 5 Is a Selective Inhibitor for c-Abl Kinase”, the following sentence needs to be added at the end of the first paragraph:. “Previously a similar approach was made to design and synthesize using a different scaffold, in that the heteroaryl and cyclic saturated ring containing amide derivatives at ‘A’ and substituted heteroaryl ring structures at ‘C’ were synthesized and tested for the potency. (1)” This erratum does not affect any of the experimental results, discussions, or conclusions reported in the paper. This article references 1 other publications. This article has not yet been cited by other publications. This article references 1 other publications.

中文翻译：

---

更正“一种新型选择性 c-Abl 抑制剂，化合物 5，可预防帕金森病的神经变性”

在第15092页第一栏“化合物5是c-Abl激酶的选择性抑制剂”部分，需要在第一段末尾添加以下句子：。“以前使用不同的支架设计和合成了类似的方法，因为在'A'处合成了含有酰胺衍生物的杂芳基和环状饱和环，在'C'处合成了取代的杂芳基环结构，并测试了其效力。(1)” 此勘误不影响论文中报告的任何实验结果、讨论或结论。本文引用了 1 篇其他出版物。这篇文章还没有被其他出版物引用。本文引用了 1 篇其他出版物。